Clinical Study

A Randomized Trial Of Pelvic Irradiation With Or Without Concurrent Weekly Cisplatin In Patients With Pelvic-Only Recurrence Of Carcinoma Of The Uterine Corpus

Posted Date: Mar 19, 2014

  • Investigator: Eric Eisenhauer
  • Co-Investigator: Kathy Amanns
  • Specialties:
  • Type of Study: Drug

The main purpose of this study is to compare radiation therapy in combination with weekly treatment with the chemotherapy drug cisplatin to the standard treatment for this type of cancer to see which is better. The standard treatment for patients with your type of cancer is radiation therapy alone. Radiation therapy is a cancer treatment that uses radiation beams from outside your body, or radioactive seeds or pellets placed directly into the tissue to kill cancer cells. Radiation therapy alone has not been very effective in treating large tumors that recur (come back) in the pelvis, lymph nodes or vagina. Radiation therapy in combination with weekly treatment with the chemotherapy drug cisplatin has been found to be very effective in treating patients with advanced cervical cancers. Another purpose of the study is to evaluate the side effects of the combination of radiation therapy and cisplatin.

Criteria:

You Are Being Asked To Take Part In This Research Study Because You Are 18 Years Of Age Or Older And You Have Been Diagnosed With Recurrent Uterine Cancer (Cancer That Has Come Back).

Keywords:

Gynecologic Oncology, Gynecology, Radiation, Recurrent, Uterine Cancer

For More Information:

Michael Blakeman
513-584-5044
michael.blakeman@uc.edu

  • Search Clinical Studies

  • Research in the News

    UC Study Finds Organs from HCV Donors May Be Safe for Liver Transplant

    A UC researcher says livers from HCV patients who test positive for theantibody made to fight the disease may pose a modest risk of infection and beacceptable for transplant